日本慢性疼痛个体化认知行为疗法:多中心随机对照试验研究方案
这项开放标签、随机、平行组优效性试验在日本多中心纳入60例20-80岁慢性疼痛持续≥3个月且EQ-5D-5L评分≤0.80的成人,1:1随机接受常规治疗(TAU)联合八次面对面个体化CBT-CP或仅TAU的等待对照,主要结局为15±2周时生活质量(EQ-5D-5L)。
要点
- 纳入60例慢性疼痛≥3个月且EQ-5D-5L≤0.80的20-80岁成人,1:1随机分组。
- 干预组接受八次面对面个体化CBT-CP联合TAU,目标14周内完成,主要结局为15±2周EQ-5D-5L。
- 干预组另设27±2周随访,以单臂前后分析探索中期持久性;分析按意向性治疗原则用线性混合模型。
核心结论
- 该试验将明确简短、有保真度保障的面对面CBT-CP项目在日本这一实施仍有限的环境中的附加价值。
- 研究结果预期可指导临床采纳、人员培训和推广,并生成关于CBT-CP对谁有益及通过何种过程获益的假设。
研究设计与样本
- 开放标签、随机、平行组优效性试验,在日本多中心开展,纳入60例20-80岁慢性疼痛持续≥3个月且EQ-5D-5L评分≤0.80的成人。
- 参与者按1:1随机分配至常规治疗(TAU)联合八次CBT-CP项目组或仅接受TAU的等待对照。
- 干预为手册化的八次面对面CBT-CP,内容包括心理教育、放松、活动节奏和认知重构,每周一次,目标在14周内完成八次;必要时可延至第15周以后,但后评估始终在15±2周进行。
- 治疗师需符合预设资格标准,并接受结构化培训、督导和保真度监测。
- 分析遵循意向性治疗原则,使用线性混合模型,报告效应量和置信区间,解释次要结局时考虑多重性。
主要发现
- 主要结局为15±2周时生活质量(EQ-5D-5L)。
- 次要结局包括疼痛强度、功能障碍、抑郁症状、灾难化思维、运动恐惧、疼痛自我效能及SF-12评估的健康相关生活质量。
- 上述结局连同预后风险和躯体症状负担将作为潜在中介或调节因素进行分析。
- 干预组接受27±2周随访,以单臂前后分析探索中期持久性。
关键数值与推荐
- 纳入标准为20-80岁成人,慢性疼痛持续≥3个月,EQ-5D-5L评分≤0.80。
- 随机化比例为1:1,干预组为TAU联合八次CBT-CP,对照组为仅TAU等待名单。
- 主要结局评估时间点为15±2周,干预目标为14周内完成八次,必要时可延至第15周以后。
- 干预组中期随访时间为27±2周。
临床怎么用
- 原文未据此给出推荐。
局限性
- 参与者与治疗师设盲不可行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic pain imposes a substantial burden on individuals and society. Cognitive behavioral therapy for chronic pain (CBT-CP) has proven effective internationally, but randomized evidence in Japan is scarce. The first Japanese trial was a single-center, 16-session videoconference program that prioritized pain intensity. In contrast, this multicenter trial tests a brief, face-to-face, individualized CBT-CP program with quality of life (QoL) as the primary outcome. METHODS: This open-label, randomized, parallel-group superiority trial enrolls 60 adults aged 20-80 years with chronic pain persisting ≥ 3 months and EQ-5D-5L scores ≤ 0.80, indicating reduced QoL. Participants are randomized 1:1 to treatment as usual (TAU) plus an eight-session CBT-CP program or to a waitlist control receiving TAU only. The manualized intervention includes psycho-education, relaxation, activity pacing, and cognitive restructuring, delivered weekly face-to-face, with the goal of completing eight sessions within 14 weeks. If necessary, sessions may extend beyond the 15th week; however, the post-assessment is always conducted at 15 ± 2 weeks irrespective of intervention timing. Therapists meet prespecified eligibility criteria and receive structured training, supervision, and fidelity monitoring. The primary outcome is QoL (EQ-5D-5L) at 15 ± 2 weeks. Secondary outcomes include pain intensity, disability, depressive symptoms, catastrophizing, fear of movement, pain self-efficacy, and health-related QoL assessed by the SF-12. These outcomes, together with prognostic risk and somatic symptom burden, will also be examined as potential mediators or moderators. The intervention group undergoes a 27 ± 2-week follow-up to explore mid-term durability in a single-arm pre/post analysis. Analyses follow the intent-to-treat principle using linear mixed models, with effect sizes and confidence intervals reported; multiplicity will be considered in interpreting secondary outcomes. Blinding of participants and therapists is not feasible. DISCUSSION: This trial will clarify the added value of a brief, fidelity-assured, face-to-face CBT-CP program in Japan, where implementation remains limited. Findings are expected to guide clinical adoption, workforce training, and dissemination, while also generating hypotheses about for whom and through which processes CBT-CP may confer benefit. TRIAL REGISTRATION: University Hospital Medical Information Network Clinical Trials Registry, UMIN000042798. Registered on 21 December 2020, https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048858 .
引用
- Hosogoshi H, Iwasa K, Fukumori T, et al. Individualized cognitive behavioral therapy for chronic pain in Japan: study protocol for a multicenter randomized controlled trial. Trials. 2025. PMID: 41219998. doi:10.1186/s13063-025-09153-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。